Interview: Aaron Motsoaledi – Minister of Health, South Africa
The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for…
Address: 65 Peter Place
Bryanston Extension 13
2021 Republic of South Africa
Tel: +27 11 840 2300
Web: http://www.alcon.com/en/alcon-locations/africa.aspx
Founded in 1945, Alcon traces its roots back to two pharmacists, Robert Alexander and William Conner, who opened a small pharmacy in Fort Worth, Texas, and combined the first syllables of their last names to create the name Alcon.
The strengths of Alcon, CIBA VISION and Novartis Ophthalmics unite into one eye care business with Alcon becoming the second largest division of Novartis. With these collective resources and scale, Alcon offers the widest spectrum of eye care products in Surgical, Pharmaceutical and Vision Care across 180 markets and runs operations in 75 countries.
Incorporated in 1977, Alcon South Africa employs nearly 90 people focused on serving the needs of health care professionals in the area.
Alcon develops, manufactures and markets surgical equipment and devices, pharmaceuticals and vision care products in more than 180 countries. At the heart of Alcon’s ability to deliver ‘best in class’ products year after year is our Research & Development organization. All of our many engineers, scientists and medical professionals are dedicated to meeting the world’s eye health needs. In 2010, we invested USD 747 million in the pursuit of new products to enhance, preserve and restore vision. Over the next five years, Alcon plans to invest approximately USD 4 billion to discover and develop new treatment solutions for vision conditions and eye diseases.
The minister of health reveals how for the first time in the country´s history the healthcare sector is following a clear roadmap with the National Development Plan, a vision for…
The managing director of Southern Medical, Malan de Villiers illustrates the sheer diversity of the company’s current activities and portfolio within South Africa as a leading implant devices company, while…
Charl Louw, Vice President Africa and Middle East at Acelity discusses the challenges of a two-tiered health system for Acelity, the significance of South Africa for the company’s global portfolio…
The managing director of MC Pharma Group, Henk Krebs illustrates how MC Pharma’s new operating structure enables the group to better service its clients, and also highlights the role of…
Ansie Savrda of ERS (pty) ltd, highlights the important role that ERS plays in helping pharmaceutical companies to efficiently navigate South Africa and Africa’s regulatory environment through the company’s broad portfolio of regulatory…
The country manager of Roche Diagnostics SA, Rajen Bhimaraj highlights the current gaps in the country’s healthcare system and elaborates on how the company’s various community initiatives, such as AmpliCare…
The founder and managing director of LT Clinical Research, one of the first wholly black-owned South African CRO, reveals how South Africa is a very conducive environment for CROs, with…
The General Manager of Boehringer Ingelheim South Africa talks about changes that are required to the healthcare system, with far more government/private partnerships, helping to unlock the country´s potential, why…
CEO of the Clicks Group, David Kneale highlights the motivations behind groups involvement in the Public Health Enhancement Fund (PHEF), and also describe the key strategies that have allowed Clicks…
The General Manager of Abbott’s Established Pharmaceuticals Division in South Africa, Gauta Phillip Mavundla illustrates how he is building the division’s presence within the region after the spinoff of AbbVie,…
Muhammad Bodhania, Managing Director of Medreich South Africa discusses potential strategic implications of the recent acquisition of Medreich by Meiji and the importance of local partnerships for global success. Can…
The CEO of BioTech Africa, Jason Lurie, evaluates the domestic and global landscape for diagnostic recombinant proteins, and highlights other developmental streams that have helped diversify the company’s portfolio. He…
See our Cookie Privacy Policy Here
